Aspirin,Nonsteroidal Anti-Inflammatory Drugs,and Epistaxis

Abstract

To assess the relationship between nonsteroidal anti-inflammatory drugs (NSAIDs) and spontaneous epistaxis in adults over 50 years old, a case control study was carried out by using a record linkage database for the population of Tayside, Scotland, which included 319,465 people. The study group consisted of 326 patients who were hospitalized with epistaxis between May 1989 and December 1992, but who had not previously been hospitalized with this diagnosis. Six community controls and 4 hospital controls, matched for age and sex to each case, were used. Previous exposure to prescribed aspirin and other NSAIDs was investigated. There was a significant association between aspirin exposure and epistaxis when either community or hospital controls were used (p <.001). Patients who had aspirin prescriptions had a relative risk of hospital admission for epistaxis of between 2.17 and 2.75, depending on the control group used. No association between non-aspirin NSAIDs and epistaxis was evident with either control group.

Keywords

aspirin case control study epistaxis nonsteroidal anti-inflammatory drugs

Get full access to this article

View all access options for this article.

References

Weiss

. Antiplatelet therapy. N Engl J Med 1978; 298: 1344–7.

Watson

Shenoi

. Drug-induced epistaxis?. J R Soc Med 1990; 83: 162–4.

Livesey

Watson

Kelly

Kesteven

. Do patients with epistaxis have drug-induced platelet dysfunction?. Clin Otolaryngol 1995; 20: 407–10.

Antiplatelet Trialists' Collaboration . Collaborative overview of randomised trials of antiplatelet therapy. Part I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106.

Antiplatelet Trialists' Collaboration . Collaborative overview of randomised trials of antiplatelet therapy. Part II: Maintenance of vascular graft or arterial patency by antiplatelet treatment. Br Med J 1994; 308: 159–67.

Antiplatelet Trialists ' Collaboration . Collaborative overview of randomised trials of antiplatelet therapy. Part III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 1994; 308: 235–45.

Evans

JMM

McDevitt

MacDonald

. The Tayside Medicines Monitoring Unit (MEMO): A record-linkage system for pharmacovigilance. Pharm Med 1995; 9: 177–84.

MacDonald

McDevitt

. The Tayside Medicines Monitoring Unit (MEMO). In: Strom

, ed. Pharmacoepidemiology. 2nd ed. Chichester, England: Wiley, 1994: 245–55.

International classification of diseases . Manual of the international classification of diseases, injuries and causes of death 1977. Vol 1. Geneva, Switzerland: World Health Organization, 1977.

10.

Evans

JMM

McMahon

McGilchrist

. Topical nonsteroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: A record linkage case-control study. Br Med J 1995; 311: 22–6.

11.

Evans

JMM

McGregor

McMahon

. Nonsteroidal anti-inflammatory drugs and hospitalization for acute renal failure. Q J Med 1995; 88: 551–7.

12.

MacDonald

. Side-effects of nonsteroidal anti-inflammatory drugs: Studies from the Tayside Medicines Monitoring Unit. In: Rainsford

, ed. Side-effects of anti-inflammatory drugs IV. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1997: 25–30.

13.

MacDonald

McMahon

Reid

Fenton

McDevitt

. Antidepressant drug use in primary care: A record linkage study in Tayside, Scotland. Br Med J 1996; 313: 860–1.

14.

SAS technical report P-217. SAS/STAT software: the PHREG procedure. Cary, NC: SAS Institute, 1991.

15.

British National Formulary 34 . A joint publication of the British Medical Association and the Royal Pharmaceutical Society of Great Britain. Bath, England: The Bath Press, September 1997.

16.

Shattil

Bennett

. Platelets and their membranes in hemostasis: Physiology and pathophysiology. Ann Intern Med 1981; 94: 108–18.

17.

Jeremy

Mikhailidis

Barradas

Kirk

Dandona

. The effect of nabumetone and its principle active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function. Br J Rheumatol 1990; 29: 116–9.

18.

The Dutch TIA Trial Study Group . A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325: 1261–6.